Phase III Study of 5LGr to Treat Tic Disorder

Clinical trial NCT01501695 · COMPLETED

Trial details

NCT number: NCT01501695
Sponsor: Tasly Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tic Disorder Tourette Syndrome Chronic Tic Disorder

Start date: 2008-01-01
Primary completion: 2010-11-01
Enrollment: 603

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.